Thus, treatment aimed at maintaining lower levels of IL-8 and GrzB and higher levels of IP-10 may suppress the progression of SOC in chronic-phase SJS/TEN cases. The gene discussed is CXCL8; the disease is toxic epidermal necrolysis.